FHTX
Foghorn Therapeutics Inc
NASDAQ · Biotechnology
$5.68
+0.45 (+8.60%)
Open$5.38
Previous Close$5.23
Day High$5.74
Day Low$5.25
52W High$37.35
52W Low$15.67
Volume—
Avg Volume695.0K
Market Cap332.74M
P/E Ratio23.36
EPS$1.12
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+410.4% upside
Current
$5.68
$5.68
Target
$28.99
$28.99
$18.54
$28.99 avg
$38.99
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 275.09M | 271.86M | 230.16M |
| Net Income | 14.43M | 13.33M | 11.49M |
| Profit Margin | 5.2% | 4.9% | 5.0% |
| EBITDA | 18.56M | 20.13M | 16.16M |
| Free Cash Flow | 14.99M | 11.27M | 12.60M |
| Rev Growth | -4.2% | -6.6% | +8.1% |
| Debt/Equity | 0.68 | 0.58 | 0.73 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |